Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
about
Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilizationInduction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury.Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury.ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling.Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP.Cell-type-specific crosstalk between p38 MAPK and Rho signaling in lung micro- and macrovascular barrier dysfunction induced by Staphylococcus aureus-derived pathogens.Mechanotransduction by GEF-H1 as a novel mechanism of ventilator-induced vascular endothelial permeability.Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.p190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury.Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.Asef controls vascular endothelial permeability and barrier recovery in the lung.Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.Stiffness-activated GEF-H1 expression exacerbates LPS-induced lung inflammationOxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus.Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation.Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via Rap1.tPA regulates pulmonary vascular activity through NMDA receptorsLysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs.Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunctionKallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis.Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6.CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent mannerAssociation between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids.Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells.Adiponectin protects against hyperoxic lung injury and vascular leakInhibitory effects on the production of inflammatory mediators and reactive oxygen species by Mori folium in lipopolysaccharide-stimulated macrophages and zebrafish.Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinaseInterleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injuryManganese superoxide dismutase is not protective in bovine pulmonary artery endothelial cells at systemic oxygen levels.Regulation of lung endothelial permeability and inflammatory responses by prostaglandin A2: role of EP4 receptor.Sirt1 Protects Endothelial Cells against LPS-Induced Barrier Dysfunction.Prostaglandin E receptor-4 receptor mediates endothelial barrier-enhancing and anti-inflammatory effects of oxidized phospholipids.Incorporation of iloprost in phospholipase-resistant phospholipid scaffold enhances its barrier protective effects on pulmonary endothelium.Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.Effects of prostaglandin lipid mediators on agonist-induced lung endothelial permeability and inflammation.Prophylactic efficacy of S-2(2-aminoethylamino)ethyl phenyl sulfide (DRDE-07) against sulfur mustard induced lung toxicity in mice.
P2860
Q30532493-2C6BCA57-2C3D-43F3-8270-662F5F51B87AQ30539903-A1F7AB5F-16C8-4893-828D-41819CF8B556Q30540011-9DBE6F1F-E10B-4492-9AB8-3BF775E57971Q33618498-5EABE17C-9C23-449F-8FC8-B9305B926EA3Q33621771-4931527C-C421-4567-9631-384AC0FB8088Q33689281-AFF0841E-5EE5-4E2E-B646-161A1DFFB7EEQ33822820-8D2E02AC-2856-4CE0-8A95-063E508F8812Q33916958-C1676371-182C-49E3-8F38-79F9068EB63DQ34305451-0779C22B-ADBD-4222-B633-54424B53F36DQ34671751-3AE88A3F-9F81-406E-B87B-DD0F93D81C78Q34715709-FEC6D03B-BC23-4631-AFDD-552C6C1195C5Q35077012-360209D7-84B3-4F54-BD9F-6032342692BDQ35138639-DC9CCD94-EEC8-44B6-8447-5147CCF9283DQ35150381-D5306B86-4EE3-47EA-8BFD-DA390FDC4176Q35178692-D83B3A56-2DC4-4FE5-AA48-58FF05401A18Q35207657-631C8613-98AE-4469-912E-5EBD1E621D4BQ35214087-F414D83D-F732-4AE3-BCD3-88BDB81C9370Q35217381-0A2E54AB-DA3C-4E95-A2F8-0E83EAE4185EQ35325265-E1D446FF-6FDD-438C-AADE-25DA2B94599EQ35658084-CA7443B8-1DFC-4485-AA7A-8F46840B2155Q35877298-B8C985C8-53DB-4F2A-936C-57D19FB20DF5Q35994462-D70A27A2-F459-48D8-8E7B-5619E245ABE5Q36061451-2852B980-DC24-40AD-9D8A-5F3D5C6D484CQ36840432-45458B8F-82CF-4D73-91D5-F9EE70DCE6D2Q37409822-1E174818-E708-4EE6-91AF-D1D1C561322DQ37723787-E1005E75-687B-44FE-8EB4-C307EEE54C33Q38753842-9565A864-93C1-4448-860C-472F490431ADQ39460874-7747012B-C5FA-4116-9017-98602B54BB4EQ41903319-B15E5C90-5A5C-4CDC-ABB3-4C6EAEDEA760Q41917160-41862253-0ABC-4DEA-89AE-B53F161C13DBQ42204829-BCAA8DDF-288A-4BCF-8914-9D1585750F58Q46247227-DEA5550C-0E93-4DA0-B3F0-73977C8452B1Q46357619-9826C520-CB20-408B-B48F-BA32ECBE438FQ47726677-81FFFC95-433D-43E2-A284-6902159CA306Q48003088-0B0AC61C-FB2A-478C-83D3-5EC953876ED7Q50915956-AE00D545-BE9B-445A-A62E-E7011514217EQ52926329-A98DE170-29F9-4E53-9E37-132A55EFB2B4
P2860
Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
@en
type
label
Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
@en
prefLabel
Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
@en
P2093
P2860
P1476
Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
@en
P2093
A A Birukova
D J Grdina
J G N Garcia
J S Murley
K G Birukov
P2860
P304
P356
10.1183/09031936.00014808
P577
2008-11-14T00:00:00Z